Mechanisms of Disease: erythropoietin—an old hormone with a new mission?
Danilo Fliser, Ferdinand H Bahlmann, Kirsten deGroot and Hermann Haller*
Correspondence *Department of Internal Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
Email haller.hermann@mh-hannover.de
After becoming established as a therapy for various anemic states, wider uses—including cardiovascular therapy—are being explored for erythropoietin. The possible mechanisms for actions in the cardiovascular and renal systems are explored in this Review, showing that the therapeutic benefits of this cytokine seem much broader than initially anticipated.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Erythropoietin and progression of CKDKidney International Original Article
Antioxidative effects of erythropoietinKidney International Original Article
Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid CommunicationKidney International Original Article
See all 13 matches for Research